ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
4Q 2023 Total Revenue of $73.9 Million; FY 2023 Total Revenue of $258.2 Million4Q 2023 Adjusted EBITDA(1) of $18.6 Million; FY 2023 Adjusted EBITD...